Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin — Paul Moayyedi (2019) | RDL Network
Paul Moayyedi, John W. Eikelboom, Jackie Bosch, Stuart J. Connolly, Leanne Dyal, Olga Shestakovska, Darryl P. Leong, Sonia S. Anand, Stefan Störk, Kelley R. Branch, Deepak L. Bhatt, Peter Verhamme, Martin O’Donnell, Aldo Maggioni, Eva Lonn, Leopoldo Soares Piegas, Georg Ertl, Matyàs Keltai, Nancy Cook Bruns, Eva Muehlhofer, Gilles R. Dagenais, Jae‐Hyung Kim, Masatsugu Hori, Philippe Gabríel Steg, Robert G. Hart, Rafael Díaz, Marco Alings, Petr Widimský, Álvaro Avezum, Jeffrey L. Probstfield, Jun Zhu, Yan Liang, Patricio López‐Jaramillo, Ajay K. Kakkar, Alexander Parkhomenko, Lars Rydén, Nana Pogosova, Antonio Dans, Fernando Laņas, Patrick Commerford, Christian Torp‐Pedersen, Tomasz J. Guzik, Dragoş Vinereanu, Andrew M. Tonkin, Basil S. Lewis, Camilo Félix, Khalid Yusoff, Kaj Metsärinne, Keith A.A. Fox, Salim Yusuf
Masafumi Ono, Yoshinobu Onuma, Hideyuki Kawashima, Hironori Hara, Chao Gao, Rutao Wang, Neil O’Leary, Edouard Benit, Luc Janssens, Maurizio Ferrario, Aleksander Żurakowski, Marcello Dominici, Kurt Huber, Paweł Buszman, Scot Garg, Joanna J. Wykrzykowska, Jan J. Piek, Peter Jüni, Christian W. Hamm, Stephan Windecker, Pascal Vranckx, Efthymios Deliargyris,
Masafumi Ono, Yoshinobu Onuma, Hideyuki Kawashima, Hironori Hara, Chao Gao, Rutao Wang, Neil O’Leary, Scot Garg, Peter Jüni, Christian Hamm, Marco Valgimigli, Stephan Windecker, Pascal Vranckx, Efthymios Deliargyris, Deepak L. Bhatt, Robert F. Storey, Patrick W. Serruys
Tobias Bonten, Jaapjan D. Snoep, Willem JJ Assendelft, Victor van der Meer, Jaap Jan Zwaginga, Frits R. Rosendaal, Jeroen Eikenboom, Johanna G. van der Bom
Thomas Vanassche, Peter Verhamme, Darryl P. Leong, Deepak L. Bhatt, Olga Shestakovska, Aldo Maggioni, Keith A.A. Fox, Eva Muehlhofer, Stuart J. Connolly, Salim Yusuf, John W. Eikelboom, Jackie Bosch
Discussion(0)
No comments yet. Be the first to comment.